30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Paul Sekhri

Track

Insider profile

Currently holds positions in Pharming Group NV, Veeva Systems Inc, Alpine Immune Sciences Inc and Ipsen SA

Performance

Overall performance
2.4
Performance over holding periods
2.4
30 days 90 days 120 days
Average return -7% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chairman of the Board of Supervisory Directors Pharming Group NV May 25, 2016 -
Independent Director Veeva Systems Inc July 7, 2014 -
Independent Director Alpine Immune Sciences Inc Feb. 25, 2016 -
Independent Director Ipsen SA May 30, 2018 -
Director Enumeral Biomedical Holdings Inc Dec. 16, 2014 - Sept. 1, 2017
Member of the Board of Supervisory Directors Pharming Group NV April 30, 2015 - May 25, 2016
Group Executive Vice President, Global Business Development and Chief Strategy Officer Teva Pharmaceutical Industries Ltd June 1, 2013 - Jan. 1, 2014
Paul Sekhri's trades of Fratelli Vineyards Ltd's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-10-30 2025-10-28
B Purchase
18,791
50.52
₹3,897,164 		18,791 50.52 ₹3,897,164
2025-10-01 2025-09-29
S Sale
1,941
281.75
₹4,081,721 		1,941 281.75 ₹4,081,721
2020-03-05 2020-03-03
FR Ipsen SA (IPN)
B Purchase
14,920
52.44
€1,996,887 		14,920 52.44 €1,996,887
2020-03-05 2020-03-02
FR Ipsen SA (IPN)
B Purchase
100
64.00
US$6,400 		100 64.00 US$6,400
2018-11-22 2018-11-19
FR Ipsen SA (IPN)
B Purchase
100
13,993.61
US$1,399,361 		100 13,993.61 US$1,399,361